The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Protein degradation pathways in Parkinson’s disease: curse or blessing
Open accessAbstract
Protein misfolding, aggregation and deposition are common disease mechanisms in many neurodegenerative diseases including Parkinson’s disease (PD). Accumulation of damaged or abnormally modified proteins may lead to perturbed cellular function and eventually to cell death. Thus, neurons rely on elaborated pathways of protein quality control and removal to maintain intracellular protein homeostasis. Molecular chaperones, the ubiquitin–proteasome system (UPS) and the autophagy–lysosomal pathway (ALP) are critical pathways that mediate the refolding or removal of abnormal proteins. The successive failure of these protein degradation pathways, as a cause or consequence of early pathological alterations in vulnerable neurons at risk, may present a key step in the pathological cascade that leads to spreading neurodegeneration. A growing number of studies in disease models and patients have implicated dysfunction of the UPS and ALP in the pathogenesis of Parkinson’s disease and related disorders. Deciphering the exact mechanism by which the different proteolytic systems contribute to the elimination of pathogenic proteins, like α-synuclein, is therefore of paramount importance. We herein review the role of protein degradation pathways in Parkinson’s disease and elaborate on the different contributions of the UPS and the ALP to the clearance of altered proteins. We examine the interplay between different degradation pathways and provide a model for the role of the UPS and ALP in the evolution and progression of α-synuclein pathology. With regards to exciting recent studies we also discuss the putative potential of using protein degradation pathways as novel therapeutic targets in Parkinson’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Crews, L., Spencer, B., Desplats, P., Patrick, C., Paulino, A., Rockenstein, E., Hansen, L., Adame, A., Galasko, D., & Masliah, E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009313 · Cited by 367
RetractedMutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500 · cited 1×
“Integral to the concept that constitutive macroautophagy is essential to neuronal survival, studies in knockout models of essential components of this pathway (Atg5 and Atg7) revealed that genetic inactivation of macroautophagy function leads to profound neurodegeneration and the formation of ubiquitinated inclusion b…”
BackgroundBjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“markedly induced under stress conditions, for instance under starvation [77].”
BackgroundMulticenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124
Protein degradation and protection against misfolded or damaged proteins.
Goldberg, A. L. (2003) · Nature · doi:10.1038/nature02263 · Cited by 2,088
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 5×
“Rat α-synuclein, containing the A53T substitution just like familial cases of PD [80], seems to be degraded by the ALP, macroautophagy [162] and CMA [33,162], although ambiguous findings concerning the latter exist [33].”
BackgroundInfluentialInclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
Autophagy: from phenomenology to molecular understanding in less than a decade
Klionsky, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2245 · Cited by 1,934
Selective autophagy mediated by autophagic adapter proteins
Johansen, T., & Lamark, T. (2011) · Autophagy · doi:10.4161/auto.7.3.14487 · Cited by 1,730
A protein conjugation system essential for autophagy
Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M. D., Klionsky, D. J., Ohsumi, M., & Ohsumi, Y. (1998) · Nature · doi:10.1038/26506 · Cited by 1,699
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341
Self-citationTor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast
Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,309
Molecular dissection of autophagy: two ubiquitin-like systems
Ohsumi, Y. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056522 · Cited by 1,240 · cited 1×
“Without going into much detail, the biogenesis of autophagic vesicles involves 35 autophagy-related genes and proteins (Atg) that form two unique ubiquitin-like conjugation systems: The Atg12Atg5 and the MAP1LC3 (microtubule-associated proteins 1A/1B light chain 3 or LC3 or Atg8)-phosphatidylethanolamine (PE) conjugat…”
BackgroundHDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., Schwartz, S. L., DiProspero, N. A., Knight, M. A., Schuldiner, O., et al. (2007) · Nature · doi:10.1038/nature05853 · Cited by 1,234 · cited 1×
“shown to induce and upregulate autophagic flux in cell culture [38, 60, 126] and Drosophila melanogaster [119] and recently in human a-synuclein transgenic mice [39].”
BackgroundRamirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,188
Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A., & Rubinsztein, D. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609532200 · Cited by 1,142
Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S. D., Ntzouni, M., Margaritis, L. H., Stefanis, L., & Vekrellis, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5699-09.2010 · Cited by 1,115 · cited 1×
“Lysosomal dysfunction was also shown to influence the secretion of a-synuclein via exosomes [2], a recently discovered mechanism that might have important implications for the seeding, regional spreading and progression of a-synuclein pathology and neuronal degeneration [43, 54].”
BackgroundThe Atg16L Complex Specifies the Site of LC3 Lipidation for Membrane Biogenesis in Autophagy
Fujita, N., Itoh, T., Omori, H., Fukuda, M., Noda, T., & Yoshimori, T. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-12-1257 · Cited by 1,081
Lithium induces autophagy by inhibiting inositol monophosphatase
Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L. J., & Rubinsztein, D. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504035 · Cited by 985
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
Potential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842
α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825
Pathogenic Lysosomal Depletion in Parkinson's Disease
Dehay, B., Bové, J., Rodríguez-Muela, N., Perier, C., Recasens, A., Boya, P., & Vila, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1920-10.2010 · Cited by 825
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Williams, A., Sarkar, S., Cuddon, P., Ttofi, E. K., Saiki, S., Siddiqi, F. H., Jahreiss, L., Fleming, A., Pask, D., Goldsmith, P., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.79 · Cited by 800 · cited 2×
“More recent studies also demonstrated that macroautophagy can be enhanced in a mTOR-independent manner [134, 161], which may provide additional targets for novel autophagy-enhancing compounds.”
BackgroundLysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Gardiner, C., Sargent, I. L., Wood, M. J. A., & Cooper, J. M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.029 · Cited by 748
HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin.
Iwata, A., Riley, B. E., Johnston, J. A., & Kopito, R. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508786200 · Cited by 719 · cited 1×
“shown to induce and upregulate autophagic flux in cell culture [38, 60, 126] and Drosophila melanogaster [119] and recently in human a-synuclein transgenic mice [39].”
BackgroundDing, W.-X., Ni, H.-M., Gao, W., Yoshimori, T., Stolz, D. B., Ron, D., & Yin, X.-M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070188 · Cited by 708
Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683
Proteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum
Smith, M. H., Ploegh, H. L., & Weissman, J. S. (2011) · Science · doi:10.1126/science.1209235 · Cited by 647
Chen, L., & Feany, M. B. (2005) · Nature Neuroscience · doi:10.1038/nn1443 · Cited by 618
Komatsu, M., Wang, Q. J., Holstein, G. R., Friedrich, V. L., Iwata, J.-I., Kominami, E., Chait, B. T., Tanaka, K., & Yue, Z. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701311104 · Cited by 614 · cited 1×
“In neurons for example, autophagosome formation and cargo sequestration can take place in neuronal processes [74].”
BackgroundAutophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Korolchuk, V. I., Mansilla, A., Menzies, F. M., & Rubinsztein, D. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.021 · Cited by 610
Small molecules enhance autophagy and reduce toxicity in Huntington's disease models
Sarkar, S., Perlstein, E. O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R. L., Webster, J. A., Lewis, T. A., O'Kane, C. J., Schreiber, S. L., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio883 · Cited by 596
Spencer, B., Potkar, R., Trejo, M., Rockenstein, E., Patrick, C., Gindi, R., Adame, A., Wyss-Coray, T., & Masliah, E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4390-09.2009 · Cited by 595
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
Alvarez-Erviti, L., Rodriguez-Oroz, M. C., Cooper, J. M., Caballero, C., Ferrer, I., Obeso, J. A., & Schapira, A. H. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 554
Microautophagy in mammalian cells: Revisiting a 40-year-old conundrum
Mijaljica, D., Prescott, M., & Devenish, R. J. (2011) · Autophagy · doi:10.4161/auto.7.7.14733 · Cited by 547
Consequences of the selective blockage of chaperone-mediated autophagy
Massey, A. C., Kaushik, S., Sovak, G., Kiffin, R., & Cuervo, A. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507436103 · Cited by 529 · cited 3×
“Although both pathways are not redundant, activation of macroautophagy under basal conditions can preserve protein homeostasis when CMA function is compromised [100].”
BackgroundInfluentialFornai, F., Schlüter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409713102 · Cited by 526
Fighting neurodegeneration with rapamycin: mechanistic insights
Bové, J., Martínez-Vicente, M., & Vila, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3068 · Cited by 525
Tong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J., & Shen, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004676107 · Cited by 501
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
(2001) · doi:10.1523/jneurosci.21-24-09549.2001 · Cited by 476
(2002) · doi:10.1016/s0896-6273(02)01125-x · Cited by 473
Rapamycin Protects against Neuron Death in In Vitro and In Vivo Models of Parkinson's Disease
Malagelada, C., Jin, Z. H., Jackson-Lewis, V., Przedborski, S., & Greene, L. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 462
The Itinerary of Autophagosomes: From Peripheral Formation to Kiss‐and‐Run Fusion with Lysosomes
Jahreiss, L., Menzies, F. M., & Rubinsztein, D. C. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00701.x · Cited by 451
Control of autophagy as a therapy for neurodegenerative disease
Harris, H., & Rubinsztein, D. C. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.200 · Cited by 447
Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway
Lee, H.-J., Khoshaghideh, F., Patel, S., & Lee, S.-J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3809-03.2004 · Cited by 445
Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult
Paxinou, E., Chen, Q., Weisse, M., Giasson, B. I., Norris, E. H., Rueter, S. M., Trojanowski, J. Q., Lee, V. M.-Y., & Ischiropoulos, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08053.2001 · Cited by 440
Karpinar, D. P., Balija, M. B. G., Kügler, S., Opazo, F., Rezaei‐Ghaleh, N., Wender, N., Kim, H., Taschenberger, G., Falkenburger, B. H., Heise, H., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.257 · Cited by 432
Endoproteolytic Activity of the Proteasome
Liu, C.-W., Corboy, M. J., DeMartino, G. N., & Thomas, P. J. (2003) · Science · doi:10.1126/science.1079293 · Cited by 421
Chu, Y., Dodiya, H., Aebischer, P., Olanow, C. W., & Kordower, J. H. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.023 · Cited by 421
Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., & Wolozin, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208641200 · Cited by 420
Degradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417
Lewy bodies are ubiquitinated: A light and electron microscopic immunocytochemical study
Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00687787 · Cited by 410
Proteasomal Inhibition by α-Synuclein Filaments and Oligomers
Lindersson, E., Beedholm, R., Højrup, P., Moos, T., Gai, W., Hendil, K. B., & Jensen, P. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306390200 · Cited by 397
Ebrahimi-Fakhari, D., Cantuti-Castelvetri, I., Fan, Z., Rockenstein, E., Masliah, E., Hyman, B. T., McLean, P. J., & Unni, V. K. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1560-11.2011 · Cited by 377
Self-citationTofaris, G. K., Layfield, R., & Spillantini, M. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03115-5 · Cited by 363
Tofaris, G. K., Razzaq, A., Ghetti, B., Lilley, K. S., & Spillantini, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308041200 · Cited by 361
Gr�nblatt, E., Mandel, S., Jacob-Hirsch, J., Zeligson, S., Amariglo, N., Rechavi, G., Li, J., Ravid, R., Roggendorf, W., Riederer, P., et al. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0212-1 · Cited by 356
Lowe, J., McDermott, H., Landon, M., Mayer, R. J., & Wilkinson, K. D. (1990) · The Journal of Pathology · doi:10.1002/path.1711610210 · Cited by 356
Xilouri, M., Vogiatzi, T., Vekrellis, K., Park, D., & Stefanis, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005515 · Cited by 354
Lysosomal Degradation of α-Synuclein in Vivo
Mak, S. K., McCormack, A. L., Manning-Boğ, A. B., Cuervo, A. M., & Di Monte, D. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074617 · Cited by 349
A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin
Sarkar, S., Krishna, G., Imarisio, S., Saiki, S., O'Kane, C. J., & Rubinsztein, D. C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm294 · Cited by 349
Betarbet, R., Canet-Aviles, R. M., Sherer, T. B., Mastroberardino, P. G., McLendon, C., Kim, J.-H., Lund, S., Na, H.-M., Taylor, G., Bence, N. F., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.003 · Cited by 342
Constitutive Activation of Chaperone-mediated Autophagy in Cells with Impaired Macroautophagy
Kaushik, S., Massey, A. C., Mizushima, N., & Cuervo, A. M. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1155 · Cited by 335
Shin, Y., Klucken, J., Patterson, C., Hyman, B. T., & McLean, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503326200 · Cited by 329
Self-citationBedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327 · cited 1×
“Finally, an exciting report by Bedford and colleagues [9] has fundamentally underscored the importance of UPSmediated protein homeostasis for neurodegeneration: A mouse model expressing a conditional deletion of the Rpt2/ PSMC1 subunit, an ATPase of the 19S regulatory complex, spatially restricted to the forebrain and…”
BackgroundParkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 325
Lavedan, C. (1998) · Genome Research · doi:10.1101/gr.8.9.871 · Cited by 320
Sardi, S. P., Clarke, J., Kinnecom, C., Tamsett, T. J., Li, L., Stanek, L. M., Passini, M. A., Grabowski, G. A., Schlossmacher, M. G., Sidman, R. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108197108 · Cited by 319
Chaperone-mediated autophagy in protein quality control
Arias, E., & Cuervo, A. M. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.10.009 · Cited by 313
Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP
Gómez-Suaga, P., Luzón-Toro, B., Churamani, D., Zhang, L., Bloor-Young, D., Patel, S., Woodman, P. G., Churchill, G. C., & Hilfiker, S. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr481 · Cited by 312
Sevlever, D., Jiang, P., & Yen, S.-H. C. (2008) · Biochemistry · doi:10.1021/bi800699v · Cited by 305
McNaught, K. S. P., Mytilineou, C., JnoBaptiste, R., Yabut, J., Shashidharan, P., Jenner, P., & Olanow, C. W. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00821.x · Cited by 304
Integration of Clearance Mechanisms: The Proteasome and Autophagy
Wong, E., & Cuervo, A. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006734 · Cited by 304
Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy
Yang, Q., She, H., Gearing, M., Colla, E., Lee, M., Shacka, J. J., & Mao, Z. (2009) · Science · doi:10.1126/science.1166088 · Cited by 304
Friedman, L. G., Lachenmayer, M. L., Wang, J., He, L., Poulose, S. M., Komatsu, M., Holstein, G. R., & Yue, Z. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5809-11.2012 · Cited by 303
Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
Gosavi, N., Lee, H.-J., Lee, J. S., Patel, S., & Lee, S.-J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208194200 · Cited by 294
Rideout, H. J., Larsen, K. E., Sulzer, D., & Stefanis, L. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00474.x · Cited by 274
Rapamycin protects against rotenone-induced apoptosis through autophagy induction
Pan, T., Rawal, P., Wu, Y., Xie, W., Jankovic, J., & Le, W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.014 · Cited by 273
Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway
Tofaris, G. K., Kim, H. T., Hourez, R., Jung, J.-W., Kim, K. P., & Goldberg, A. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109356108 · Cited by 271
A Precipitating Role for Truncated α-Synuclein and the Proteasome in α-Synuclein Aggregation
Liu, C.-W., Giasson, B. I., Lewis, K. A., Lee, V. M., DeMartino, G. N., & Thomas, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501508200 · Cited by 269
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
Qiao, L., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., Yacoubian, T. A., Wilson, S., Xie, Z.-L., Speake, L. D., Parks, R., Crabtree, D., et al. (2008) · Molecular Brain · doi:10.1186/1756-6606-1-17 · Cited by 263
Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy
Choubey, V., Safiulina, D., Vaarmann, A., Cagalinec, M., Wareski, P., Kuum, M., Zharkovsky, A., & Kaasik, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132514 · Cited by 262
Bodner, R. A., Outeiro, T. F., Altmann, S., Maxwell, M. M., Cho, S. H., Hyman, B. T., McLean, P. J., Young, A. B., Housman, D. E., & Kazantsev, A. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511256103 · Cited by 256
Self-citationMcLean, P. J., Kawamata, H., & Hyman, B. T. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00113-0 · Cited by 235
Self-citationMcNaught, K. S. P., Belizaire, R., Jenner, P., Olanow, C. W., & Isacson, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00296-3 · Cited by 232
Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome
Emmanouilidou, E., Stefanis, L., & Vekrellis, K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.008 · Cited by 221
Ii, K., ITO, H., TANAKA, K., & HIRANO, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199702000-00002 · Cited by 215
Tong, Y., Giaime, E., Yamaguchi, H., Ichimura, T., Liu, Y., Si, H., Cai, H., Bonventre, J. V., & Shen, J. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-2 · Cited by 214
Meredith, G. E., Totterdell, S., Petroske, E., Santa Cruz, K., Callison, R. C., & Lau, Y.-S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03514-x · Cited by 212
Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement
Pan, T., Kondo, S., Zhu, W., Xie, W., Jankovic, J., & Le, W. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.06.003 · Cited by 212
Autophagy for tissue homeostasis and neuroprotection
Mariño, G., Madeo, F., & Kroemer, G. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.10.001 · Cited by 195
Liani, E., Eyal, A., Avraham, E., Shemer, R., Szargel, R., Berg, D., Bornemann, A., Riess, O., Ross, C. A., Rott, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401081101 · Cited by 193
Lennox, G., Lowe, J., Morrell, K., Landon, M., & Mayer, R. J. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.1.67 · Cited by 193
Fornai, F., Lenzi, P., Gesi, M., Ferrucci, M., Lazzeri, G., Busceti, C. L., Ruffoli, R., Soldani, P., Ruggieri, S., Alessandrì, M. G., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08955.2003 · Cited by 190
Klionsky, D. J., Cuervo, A. M., Dunn, W. A., Levine, B., van der Klei, I. J., & Seglen, P. O. (2007) · Autophagy · doi:10.4161/auto.4377 · Cited by 174
Rott, R., Szargel, R., Haskin, J., Shani, V., Shainskaya, A., Manov, I., Liani, E., Avraham, E., & Engelender, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704809200 · Cited by 174
α-Synuclein fate is determined by USP9X-regulated monoubiquitination
Rott, R., Szargel, R., Haskin, J., Bandopadhyay, R., Lees, A. J., Shani, V., & Engelender, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105725108 · Cited by 174
Analysis of α-Synuclein-associated Proteins by Quantitative Proteomics
Zhou, Y., Gu, G., Goodlett, D. R., Zhang, T., Pan, C., Montine, T. J., Montine, K. S., Aebersold, R. H., & Zhang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405456200 · Cited by 173
Ubiquitination of -synuclein by Siah-1 promotes -synuclein aggregation and apoptotic cell death
Lee, J. T., Wheeler, T. C., Li, L., & Chin, L.-S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm363 · Cited by 170
Biasini, E., Fioriti, L., Ceglia, I., Invernizzi, R., Bertoli, A., Chiesa, R., & Forloni, G. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02152.x · Cited by 167
Involvement of macroautophagy in the dissolution of neuronal inclusions
Rideout, H. J., Lang-Rollin, I., & Stefanis, L. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.008 · Cited by 167
Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway
Klucken, J., Poehler, A.-M., Ebrahimi‐Fakhari, D., Schneider, J., Nuber, S., Rockenstein, E. M., Schlötzer-Schrehardt, U. M., Hyman, B. T., McLean, P. J., Masliah, E., et al. (2012) · Autophagy · doi:10.4161/auto.19371 · Cited by 163
Self-citationAutophagy-mediated clearance of aggresomes is not a universal phenomenon
Wong, E. S. P., Tan, J. M. M., Soong, W.-E., Hussein, K., Nukina, N., Dawson, V. L., Dawson, T. M., Cuervo, A. M., & Lim, K.-L. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn157 · Cited by 159
Inhibitory effects of pesticides on proteasome activity: Implication in Parkinson's disease
Wang, X.-F., Li, S., Chou, A. P., & Bronstein, J. M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.012 · Cited by 158
Protein quality control in the ER: balancing the ubiquitin checkbook
Claessen, J. H. L., Kundrat, L., & Ploegh, H. L. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.09.010 · Cited by 158
Yu, W. H., Dorado, B., Figueroa, H. Y., Wang, L., Planel, E., Cookson, M. R., Clark, L. N., & Duff, K. E. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080928 · Cited by 155 · cited 10×
“The resulting lipidated form of LC3, LC3-II, is attached to both sides of the autophagosome membrane but is removed from the outer membrane before fusion with lysosomes occurs.”
BackgroundResultInfluentialWong, A. S. L., Lee, R. H. K., Cheung, A. Y., Yeung, P. K. K., Chung, S. K., Cheung, Z. H., & Ip, N. Y. (2011) · Nature Cell Biology · doi:10.1038/ncb2217 · Cited by 155
Vernon, A. C., Johansson, S., & Modo, M. (2010) · BMC Neuroscience · doi:10.1186/1471-2202-11-1 · Cited by 153
Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease
Tanji, K., Mori, F., Kakita, A., Takahashi, H., & Wakabayashi, K. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.022 · Cited by 152
Machiya, Y., Hara, S., Arawaka, S., Fukushima, S., Sato, H., Sakamoto, M., Koyama, S., & Kato, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.141952 · Cited by 151
Rideout, H. J., & Stefanis, L. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1173 · Cited by 147
Characterization of chronic low‐level proteasome inhibition on neural homeostasis
Ding, Q., Dimayuga, E. R., Martin, S. K., Bruce‐Keller, A. J., Nukala, V. N., Cuervo, A. M., & Keller, J. N. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01885.x · Cited by 146
Dopamine-modified α-synuclein blocks chaperone-mediated autophagy
Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J., Mosharov, E. V., Hodara, R., Fredenburg, R., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 144
Proteasome inhibition and Parkinson's disease modeling
Bové, J., Zhou, C. H., Jackson-Lewis, V. R., Taylor, J. P., Chu, Y., Rideout, H. J., Wu, D.-C., Kordower, J. H., Petrucelli, L., & Przedborski, S. (2006) · Annals of Neurology · doi:10.1002/ana.20937 · Cited by 143
Kordower, J. H., Kanaan, N. M., Chu, Y., Suresh Babu, R., Stansell, J., Terpstra, B. T., Sortwell, C. E., Steece-Collier, K., & Collier, T. J. (2006) · Annals of Neurology · doi:10.1002/ana.20935 · Cited by 141
α-Synuclein Protofibrils Inhibit 26 S Proteasome-mediated Protein Degradation
Zhang, N., Tang, Z., & Liu, C.-W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710560200 · Cited by 132
Ancolio, K., da Costa, C. A., Uéda, K., & Checler, F. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01049-1 · Cited by 128
Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
Liu, K., Shi, N., Sun, Y., Zhang, T., & Sun, X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0909-8 · Cited by 118
Sawada, H., Kohno, R., Kihara, T., Izumi, Y., Sakka, N., Ibi, M., Nakanishi, M., Nakamizo, T., Yamakawa, K., Shibasaki, H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308434200 · Cited by 117
Casarejos, M. J., Solano, R. M., Gómez, A., Perucho, J., de Yébenes, J. G., & Mena, M. A. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.01.008 · Cited by 114
Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease
Blandini, F., Sinforiani, E., Pacchetti, C., Samuele, A., Bazzini, E., Zangaglia, R., Nappi, G., & Martignoni, E. (2006) · Neurology · doi:10.1212/01.wnl.0000198511.09968.b3 · Cited by 113
Edelmann, M. J., Nicholson, B., & Kessler, B. M. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002031 · Cited by 109
Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
Kalia, S. K., Kalia, L. V., & McLean, P. J. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710793237386 · Cited by 108
Self-citationProteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models
Sun, F., Anantharam, V., Zhang, D., Latchoumycandane, C., Kanthasamy, A., & Kanthasamy, A. G. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.06.006 · Cited by 107
Lack of nigrostriatal pathology in a rat model of proteasome inhibition
Manning-Bog, A., Reaney, S. H., Chou, V., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20938 · Cited by 106
Proteasome inhibition modeling nigral neuron degeneration in Parkinson’s disease
Xie, W., Li, X., Li, C., Zhu, W., Jankovic, J. J., & Le, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06914.x · Cited by 105
Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y
Xiong, N., Jia, M., Chen, C., Xiong, J., Zhang, Z., Huang, J., Hou, L., Yang, H., Cao, X., Liang, Z., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.031 · Cited by 105
Proteasome dysfunction in aged human α-synuclein transgenic mice
Chen, L., Thiruchelvam, M. J., Madura, K., & Richfield, E. K. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.004 · Cited by 103
Dopamine induces proteasome inhibition in neural PC12 cell line
Keller, J. N., Huang, F. F., Dimayuga, E. R., & Maragos, W. F. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00412-3 · Cited by 99
α-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability
Chen, Q., Thorpe, J. A., & Keller, J. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501308200 · Cited by 95
Molecular Chaperones in Parkinson's Disease – Present and Future
Ebrahimi‐Fakhari, D., Wahlster, L., & McLean, P. J. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11044 · Cited by 92
Self-citationBrain proteasomal function in sporadic Parkinson's disease and related disorders
Furukawa, Y., Vigouroux, S., Wong, H., Guttman, M., Rajput, A. H., Ang, L. C., Briand, M., Kish, S. J., & Briand, Y. (2002) · Annals of Neurology · doi:10.1002/ana.10207 · Cited by 92
Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons
Schapira, A. H. V., Cleeter, M. W. J., Muddle, J. R., Workman, J. M., Cooper, J. A. D., & King, R. H. M. (2006) · Annals of Neurology · doi:10.1002/ana.20934 · Cited by 91
Enhanced Autophagy from Chronic Toxicity of Iron and Mutant A53T α-Synuclein
Chew, K. C. M., Ang, E., Tai, Y. K., Tsang, F., Lo, S. Q., Ong, E., Ong, W.-Y., Shen, H., Lim, K., Dawson, V. L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268409 · Cited by 88
Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy
Menzies, F. M., Hourez, R., Imarisio, S., Raspe, M. A., Sadiq, O., Chandraratna, D., O’Kane, C. J., Rock, K. L., Reits, E. A., Goldberg, A. L., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq385 · Cited by 88
17-AAG Induces Cytoplasmic α-Synuclein Aggregate Clearance by Induction of Autophagy
Riedel, M., Goldbaum, O., Schwarz, L., Schmitt, S., & Richter-Landsberg, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008753 · Cited by 87 · cited 2×
“Mutant A53T and A30P a-synuclein are degraded by both the UPS [10, 160, 171, 173] and macroautophagy [129, 132, 160, 173, 175], although this was questioned in other studies [3, 82].”
BackgroundResultHigashi, S., Moore, D. J., Yamamoto, R., Minegishi, M., Sato, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., Hino, H., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b44ed8 · Cited by 85
Parkin Directly Modulates 26S Proteasome Activity
Um, J. W., Im, E., Lee, H. J., Min, B., Yoo, L., Yoo, J., Lübbert, H., Stichel-Gunkel, C. C., Cho, H.-S., Yoon, J. B., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2862-09.2010 · Cited by 83
Wu, G., Wang, X., Feng, X., Zhang, A., Li, J., Gu, K., Huang, J. A., Pang, S., Dong, H., Gao, H., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.013 · Cited by 81
Mechanisms of rotenone-induced proteasome inhibition
Chou, A. P., Li, S., Fitzmaurice, A. G., & Bronstein, J. M. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.04.006 · Cited by 80
Proteasome inhibitor-induced model of Parkinson's disease
McNaught, K. S. P., & Olanow, C. W. (2006) · Annals of Neurology · doi:10.1002/ana.20936 · Cited by 79
Reproducible nigral cell loss after systemic proteasomal inhibitor administration to rats
Zeng, B., Bukhatwa, S., Hikima, A., Rose, S., & Jenner, P. G. (2006) · Annals of Neurology · doi:10.1002/ana.20932 · Cited by 76
Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition
Miwa, H., Kubo, T., Suzuki, A., Nishi, K., & Kondo, T. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.024 · Cited by 76
Prigione, A., Piazza, F., Brighina, L., Begni, B., Galbussera, A., DiFrancesco, J. C., Andreoni, S., Piolti, R., & Ferrarese, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.022 · Cited by 76
Bukhatwa, S., Zeng, B., Rose, S., & Jenner, P. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.045 · Cited by 70
Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies
Barrachina, M., Castaño, E., Dalfó, E., Maes, T., Buesa, C., & Ferrer, I. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.005 · Cited by 69
Parkinson's disease involves autophagy and abnormal distribution of cathepsin L
Li, L., Wang, X., Fei, X., Xia, L., Qin, Z., & Liang, Z. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.068 · Cited by 68
Higashi, S., Moore, D. J., Minegishi, M., Kasanuki, K., Fujishiro, H., Kabuta, T., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., et al. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318211c86a · Cited by 67
Kim, Y., Rane, A., Lussier, S. J., & Andersen, J. K. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22700 · Cited by 67
Lichtenberg, M., Mansilla, A., Zecchini, V. R., Fleming, A., & Rubinsztein, D. C. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.81 · Cited by 66
Unni, V. K., Weissman, T. A., Rockenstein, E. M., Masliah, E., McLean, P. J., & Hyman, B. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010589 · Cited by 63
Self-citationEbrahimi-Fakhari, D., McLean, P. J., & Unni, V. K. (2012) · Autophagy · doi:10.4161/auto.8.2.18938 · Cited by 61
Self-citationMolecular Chaperones and Co-Chaperones in Parkinson Disease
Dimant, H., Ebrahimi‐Fakhari, D., & McLean, P. J. (2012) · The Neuroscientist · doi:10.1177/1073858412441372 · Cited by 60
Self-citationRideout, H. J., Dietrich, P., Wang, Q., Dauer, W. T., & Stefanis, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405146200 · Cited by 59
α-Synuclein levels modulate Huntington's disease in mice
Corrochano, S., Renna, M., Carter, S., Chrobot, N., Kent, R., Stewart, M. E., Cooper, J. F., Brown, S. D. M., Rubinsztein, D. C., & Acevedo‐Arozena, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr477 · Cited by 55
Proteasome inhibition in medaka brain induces the features of Parkinson’s disease
Matsui, H., Ito, H., Taniguchi, Y., Inoue, H., Takeda, S., & Takahashi, R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06918.x · Cited by 52
Kwak, S., Masaki, T., Ishiura, S., & Sugita, H. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90751-e · Cited by 50
l-DOPA Impairs Proteasome Activity in Parkinsonism through D1Dopamine Receptor
Berthet, A., Bézard, E., Porras, G., Fasano, S., Barroso‐Chinea, P., Dehay, B., Martínez, A., Thiolat, M.-L., Nosten‐Bertrand, M., Giros, B., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1541-11.2012 · Cited by 43
Zeng, B. ‐., Iravani, M. M., Lin, S., Irifune, M., Kuoppamäki, M., Al‐Barghouthy, G., Smith, L., Jackson, M. J., Rose, S., Medhurst, A. D., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04718.x · Cited by 41
L‐dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells
Yoshimoto, Y., Nakaso, K., & Nakashima, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2004.12.091 · Cited by 35
MacInnes, N., Iravani, M. M., Perry, E. K., Piggott, M. A., Perry, R., Jenner, P. G., & Ballard, C. G. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0027-6 · Cited by 33
Caneda-Ferrón, B., Girolamo, L. A. D., Costa, T. C. S., Beck, K. E., Layfield, R., & Billett, E. E. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05130.x · Cited by 32
Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration
Mathur, B. N., Neely, M. D., Dyllick‐Brenzinger, M., Tandon, A., & Deutch, A. Y. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.076 · Cited by 29
Ullrich, C., Mlekusch, R., Kuschnig, A., Marksteiner, J., & Humpel, C. (2010) · Current Alzheimer Research · doi:10.2174/156720510792231766 · Cited by 29
Batelli, S., Peverelli, E., Rodilossi, S., Forloni, G., & Albani, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.030 · Cited by 27
Yamada, S., Niwa, J., Ishigaki, S., Takahashi, M., Ito, T., Sone, J., Doyu, M., & Sobue, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601274200 · Cited by 18
McNaught, K. S. P., & Olanow, C. W. (2009) · Annals of Neurology · doi:10.1002/ana.21662 · Cited by 14
WITHDRAWN: Therapeutic effects of rapamycin on MPTP-induced Parkinsonism in mice
Liu, K., Liu, C., Shen, L., Shi, J., Zhang, T., Zhou, Y., Zhou, L., & Sun, X. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.05.011 · Cited by 7
Studying protein degradation pathways in vivo using a cranial window-based approach
Unni, V. K., Ebrahimi‐Fakhari, D., Vanderburg, C. R., McLean, P. J., & Hyman, B. T. (2010) · Methods · doi:10.1016/j.ymeth.2010.12.032 · Cited by 4
Self-citationTherapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
LiuNan, K., Sun, S., & Sun, T. (2013) · Cited by 4
Cited by
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis
John van Geest Centre for Brain Repair, D. O. C. N., Kouli, A., Torsney, K. M., Department of Medicine for the Elderly, C. U. H. N. F. T., Clinical Gerontology Unit, D. O. P. H. A. P. C., Kuan, W.-L., & John van Geest Centre for Brain Repair, D. O. C. N. (2018) · Parkinson’s Disease: Pathogenesis and Clinical Aspects · doi:10.15586/codonpublications.parkinsonsdisease.2018.ch1 · Cited by 507
Protective and toxic roles of dopamine in Parkinson's disease
Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 498
Mitochondrial Dysfunction in Parkinson’s Disease
Moon, H. E., & Paek, S. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.103 · Cited by 455
McNeill, A., Magalhaes, J., Shen, C., Chau, K.-Y., Hughes, D., Mehta, A., Foltynie, T., Cooper, J. M., Abramov, A. Y., Gegg, M., et al. (2014) · Brain · doi:10.1093/brain/awu020 · Cited by 321
Metadata
- Authors
- Ebrahimi-Fakhari, D., Wahlster, L., & McLean, P. J.
- Venue
- Acta Neuropathologica
- Published
- 2012-06-29
- Volume
- 124
- Issue
- 2
- Pages
- 153-172
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2052004580
- Cited by
- 253
- References
- 186
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.